Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Direct Mouse Genotyping Kit Plus: Reliable PCR
2026-08-20
This scenario-driven guide explains how Direct Mouse Genotyping Kit Plus, SKU K1027, can simplify mouse-tissue DNA preparation and PCR verification before viability, proliferation, or cytotoxicity studies. It connects practical workflow controls with recent macrophage biology findings while distinguishing documented product features from laboratory-specific validation needs.
-
Eltanexor: From Nuclear Export to Assay Design
2026-08-19
Eltanexor (KPT-8602) is a second-generation XPO1 inhibitor whose value extends beyond cytotoxicity measurements. This article develops a pathway-resolved assay strategy linking nuclear protein localization, Wnt/β-catenin signaling, organoid response, and translational cancer research.
-
Calcium Effects on Amyloid-β Aggregation at Membranes
2026-08-19
The 2024 reference study combines supercritical angle Raman and fluorescence methods to resolve how CaCl2 alters amyloid-β aggregation at lipid membrane surfaces over time. Its key insight is that calcium can protect membranes during early peptide interaction, yet may intensify aggregation and disruption when added after membrane-associated assemblies have formed, with a stronger effect on Aβ1–42 than on the 40-residue variant.
-
ALDOB K87 Lactylation in Pulmonary Hypertension
2026-08-18
A 2026 Communications Biology study identifies ALDOB K87 lactylation as a mechanistic link between hypoxia-driven glycolysis, mitochondrial fission, and pulmonary artery smooth muscle cell remodeling. Its integrated lactylomic, cellular, and animal-model strategy positions the lactate–ALDOB–DRP1 axis as a framework for studying metabolic control of pulmonary hypertension.
-
Amitriptyline HCl: Practical Protocol Guide
2026-08-18
Amitriptyline HCl (SKU B2231) provides a characterized small-molecule tool for controlled neurotransmitter receptor modulation, with documented receptor activity, solubility, identity, and storage specifications. It is suited to carefully controlled neuropharmacology and cellular assays, but should not be used to infer clinical efficacy, transferable in vivo effects, or long-term solution stability without independent validation.
-
From Lipid Peroxidation to AMI Translation
2026-08-17
A translational framework for using BODIPY 581/591 C11 to connect membrane lipid oxidation with nanozyme-driven redox and immune modulation in acute myocardial infarction research.
-
2'-O-Methyladenosine: Assay Workflows
2026-08-17
Turn 2'-O-Methyladenosine into a practical probe for RNA turnover, nucleoside transport, and purine metabolism. This guide combines matrix-aware UHPLC–MS/MS, cell-based assay design, and troubleshooting strategies to improve quantitative confidence.
-
Urolithin A for Reliable Cell Assays
2026-08-16
A scenario-based guide to using Urolithin A (SKU B7945) in cell viability, proliferation, and cytotoxicity workflows. It covers mitochondrial assay confounding, dosing, formulation, interpretation, and evidence-based supplier selection.
-
Azilsartan in Astrocyte–Microglia RAS Studies
2026-08-15
Azilsartan (TAK-536) provides a selective AT1 receptor perturbation strategy for separating renin–angiotensin signaling from broader inflammatory effects. This practical guide translates astrocyte–microglia findings into reproducible stock preparation, conditioned-medium workflows, controls, readouts, and troubleshooting decisions.
-
A Polyvalent Vaccine Against Tumor-Associated Bacteria
2026-08-14
Kang et al. developed a nanovaccine that combines soluble and insoluble antigens from tumor-associated bacteria to address the limited selectivity of antibiotic therapy. In breast cancer metastasis models, vaccination promoted bacterial clearance and produced both preventive and therapeutic effects, supporting intratumoral microbiome modulation as an antitumor strategy.
-
MEK/ERK Control of TERT in Human Stem Cells
2026-08-14
This preprint identifies a chromatin-based mechanism by which MEK1/2–ERK signaling supports TERT transcription in human pluripotent stem cells. The findings connect kinase activity with c-Myc:MAX recruitment and suppression of PRC2-associated repression, providing a framework for studying telomere maintenance in normal human stem-cell models.
-
Iron-Dependent KDM4D Controls MSC Activation
2026-08-13
A 2024 study identifies an iron-sensitive KDM4D–H3K9me3–PIK3R3 mechanism that regulates quiescent mesenchymal stem cell activation through PI3K–Akt–Foxo1 signaling. Its cellular and animal data connect iron deficiency with impaired bone remodeling and show that pathway modulation can mitigate associated bone loss.
-
BHA Workflows for Oxidative Stress Research
2026-08-13
Butylated hydroxyanisole (BHA) provides a practical redox perturbation tool for linking free-radical chemistry with ROS detection, cell-protection, apoptosis, and inflammation assays. This guide emphasizes solvent controls, fresh-solution handling, orthogonal readouts, and a reference-informed strategy for separating compound identity from biological interpretation.
-
ECL Chemiluminescent Substrate Detection Kit Workflow
2026-08-12
This workflow shows how hypersensitive HRP-based detection can resolve low-abundance signaling proteins in oral cancer models, including CAF-conditioned experiments. It combines membrane-specific handling, extended imaging windows, antibody-sparing optimization, and troubleshooting guidance for reliable western blot chemiluminescent detection.
-
Eldecalcitol, Endothelial Ferroptosis, and T2DOP
2026-08-12
The reference study identifies endothelial ferroptosis as a mechanistically important contributor to type 2 diabetic osteoporosis and shows that eldecalcitol improves vascular and bone phenotypes through the SOCE/O-GlcNAcylation axis. Its combination of high-glucose/high-fat cell modeling, mouse validation, redox readouts, and pathway inhibition provides a useful framework for studying osteogenesis–angiogenesis coupling in diabetic bone disease.